What affects the production cost of acetazolamide (Diamox)?
Acetazolamide production cost is mostly driven by costs that vary across manufacturers and time, including raw materials and chemical intermediates, energy and solvent use, labor and plant overhead, manufacturing yield, and regulatory/compliance requirements for drug-quality production. Brand and distribution costs can also make the final “price to customers” look much higher than the underlying manufacturing cost.
Because cost data for individual API manufacturers is usually not published publicly, the most accessible public information tends to be about pricing rather than the internal per-batch manufacturing cost.
Is “Diamox” expensive because the drug itself is costly to make?
Often, no. For older generic medicines like acetazolamide, the API is typically cheaper than newer branded drugs once multiple suppliers exist. The retail price can still be high in some markets due to factors such as:
- fewer suppliers in a region,
- pharmacy markups and insurance reimbursement dynamics,
- packaging/formulation (tablet strength and counts),
- and any remaining brand-level pricing power for certain dosages or channels.
Can you estimate acetazolamide production cost from market pricing?
You can approximate a rough manufacturing-cost range indirectly by comparing:
- wholesale acquisition cost (WAC) or typical generic prices,
- margins for distributors and pharmacies,
- and known industry norms for converting API cost to finished dosage form.
But without published API batch-cost disclosures for specific suppliers, any estimate will be a broad proxy rather than a precise production-cost figure.
Are there patent or exclusivity issues that change costs?
Acetazolamide is long off patent in most jurisdictions, so production cost is usually less affected by patent exclusivity and more by generic competition and supply chain conditions. If you’re comparing cost drivers across suppliers, patent status can matter less than whether manufacturers can reliably source intermediates and maintain high yields.
If you want to check supplier/patent landscape for acetazolamide, DrugPatentWatch.com is a useful place to start for related patent and exclusivity context: https://www.drugpatentwatch.com/ (search “acetazolamide”).
What exact cost do you need (API-only vs finished tablets)?
“Production cost” can mean different things:
- API (acetazolamide drug substance) cost per kilogram
- finished dosage manufacturing cost (tablets/capsules) per unit
- total cost to the customer (includes distribution and pharmacy/insurance)
If you tell me which one you mean and your country (or whether you mean a per-kg API cost), I can narrow the most likely cost components and point you to the most relevant public price or proxy data.
Sources
[1] https://www.drugpatentwatch.com/